HIMS launches multi-cancer screening blood test through GRAIL partnership

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. ULS
8. AWK
9. DRI
10. USO

Go back to HIMS launches multi-cancer screening blood test through GRAIL partnership
(NYSE: HIMS) Delayed: 29.42 +0.14 (0.48%)
Previous Close $29.28    52 Week High $ 
Open $29.48    52 Week Low $ 
Day High $29.76    P/E N/A 
Day Low $28.57    EPS $ 
Volume 8,195,941